CN108892718A - A kind of Epinephelus coioides antimicrobial petide and its application - Google Patents
A kind of Epinephelus coioides antimicrobial petide and its application Download PDFInfo
- Publication number
- CN108892718A CN108892718A CN201810711517.XA CN201810711517A CN108892718A CN 108892718 A CN108892718 A CN 108892718A CN 201810711517 A CN201810711517 A CN 201810711517A CN 108892718 A CN108892718 A CN 108892718A
- Authority
- CN
- China
- Prior art keywords
- epinephelus coioides
- albumen
- antimicrobial
- epinephelus
- coioides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/461—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from fish
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
- A23K20/147—Polymeric derivatives, e.g. peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/80—Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Polymers & Plastics (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Animal Husbandry (AREA)
- Food Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Transplantation (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Birds (AREA)
- Marine Sciences & Fisheries (AREA)
- Insects & Arthropods (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention discloses a kind of Epinephelus coioides antimicrobial petides, antibacterial peptide is Epinephelus coioides CD59 albumen, its amino acid sequence is as shown in SEQ ID NO.1 or amino acid sequence shown in SEQ ID NO.1 is substituted, lacks and/or increases one or more amino acid and/or end modified and have same or higher active albumen.A kind of Epinephelus coioides antimicrobial petide provided by the invention can be applied to preparation fish especially grouper immune formulation or feed addictive, have broad application prospects the experiment proved that can inhibit the growth activity of vibrio alginolyticus;The present invention obtains the CD59 gene order of Epinephelus coioides for the first time, not only enrich the gene pool of grouper, and can be applied to preparation and reorganization albumen, antibacterial bacteriostatic additive and fish immunity preparation, new practical basis is provided for the physiologic immunity research of Epinephelus coioides.
Description
Technical field
The invention belongs to genetic engineering research and development technology fields, and in particular to a kind of Epinephelus coioides antimicrobial petide and its application.
Background technique
Epinephelus coioides (Epinepheluscoioides) belong to Perciformes (Perciformes) , Sushi section
(Serranidae), Epinephelinae (Epinephelinae), Epinephelus (Epinephelus) are that the reef of water warm is dwelt fish
Class, the Indian Ocean and it is Pacific the torrid zone, subtropical seas it is widely distributed.Epinephelus is in one of rare seafood fish, meat
Matter is delicious, and by liking for various regions consumer, economic value is huge.But due to facing to current climate change sharply
Disaster and the quality problem seriously polluted, it is high so as to cause its pathogenicity rate and the death rate, the artificial of grouper is supported
It grows and causes serious economic strike.Vibrio alginolyticus is common pathogeny bacterium, cultivates and passes through after the onset of grouper infection vibrio alginolyticus
It is often used antibiotic to be handled, this not only brings secondary pollution also to bring food-safety problem to environment, to seriously make
The about effective development of Grouper cultivating industry.Safely and effectively biological antibiosis agent can for Grouper cultivating industry for research and development
Sustainable development has important practical usage and application value.
CD59 albumen belongs to 6 superfamily of leukocyte antigens, is glycoprotein widely distributed in a kind of body, has included 4-
Three finger domains of 5 conservative disulfide bond.In addition, CD59 albumen, which includes one, can be incorporated into cellular phospholipid bilayer
GPI anchoring domain.Although 6 superfamily member of leukocyte antigens is all containing conservative " CCXXXXCN " structural domain, only
There is CD59 albumen that can regulate and control to complement system, and the disulfide bond pattern on CD59 albumen has also assisted in complement system
Inhibiting effect.It is well known that the activation of complement signal all concentrates on the MAC component in downstream, but CD59 albumen can pass through
It is directly bound directly with C8a or C9b, to effectively inhibit the process that C9 participates in C5b-9 assembling.In addition, nearest research
It was found that CD59 albumen can be used as a multi-functional signaling molecule, immunity of organism is exercised non-dependent in complement pathway
Immunoregulation effect, can directly participate in the activation of T cell, also can by regulation exocytosis albumen VAMP2 and
Syntaxin-1, can also be by regulating and controlling the expression of DAF so as to cause the growth of tumour cell to adjust the secretion of insulin.
Although some scholars are to zebra fish (Sun etc., 2013), bolti (Gan etc. 2015), Larimichthys crocea, rainbow trout and channel catfish
In equal fish CD59 albumen have research (Liu et al, 2007;Papanastasiou et al,2007;Yeh et al,
2007), but Epinephelus coioides CD59 albumen is used to that vibrio alginolyticus growth to be inhibited temporarily to have not been reported.
Summary of the invention
The purpose of the present invention is to provide a kind of Epinephelus coioides antimicrobial petide and its applications.
The technical solution adopted by the present invention is that:
A kind of Epinephelus coioides antimicrobial petide, antibacterial peptide are Epinephelus coioides CD59 albumen, amino acid sequence such as SEQ ID
Shown in NO.1 or amino acid sequence shown in SEQ ID NO.1 is substituted, lacks and/or increases one or more amino
It is sour and/or end modified and there is same or higher active albumen.
SEQ ID NO.1:
MKRSLGICLVICSALIGLGSAIRCYSCKDYTASCTKQRECSYDDACLTLTERGGMTYRQCLKYSDCEYGRLSQMFPQ
VSSFTFKCCNSDLCNSAPSSASMSVIGLLASAAVMWWCIH。
Encode the gene of above-mentioned Epinephelus coioides antimicrobial petide.
Further, the nucleotide sequence of gene is as shown in SEQ ID NO.2.
SEQ ID NO.2:
ATGAAGCGCTCCCTGGGGATCTGTCTGGTGATCTGCTCCGCTCTGATCGGACTGGGATCGGCCATCCGGTGTTACAG
CTGTAAGGACTACACAGCCAGCTGCACCAAACAACGAGAGTGTAGCTATGACGATGCCTGTCTCACACTCACCGAGA
GAGGTGGAATGACTTACCGTCAGTGTCTGAAGTACTCAGACTGTGAGTACGGCCGACTGTCCCAAATGTTCCCCCAG
GTCTCCAGTTTCACCTTCAAGTGCTGCAACTCAGATCTGTGTAACTCCGCCCCCTCCTCTGCATCGATGTCTGTGAT
TGGTCTTCTGGCCTCAGCGGCAGTCATGTGGTGGTGCATCCACTGA。
A kind of cloning vector, contains said gene.
A kind of expression vector, contains said gene.
The method for producing Epinephelus coioides antimicrobial petide, including above-mentioned expression vector is imported in host cell, expression obtains
Epinephelus coioides antimicrobial petide.
Application of the above-mentioned Epinephelus coioides antimicrobial petide in preparation vibrio alginolyticus growth inhibitor.
A kind of aquatic livestock immune formulation, wherein containing above-mentioned Epinephelus coioides antimicrobial petide.
A kind of aquatic animal feed additive, wherein containing above-mentioned Epinephelus coioides antimicrobial petide.
The beneficial effects of the invention are as follows:
(1) the present invention provides a kind of Epinephelus coioides antimicrobial petides, the experiment proved that can inhibit the growth of vibrio alginolyticus
Activity can be applied to preparation fish especially grouper immune formulation or feed addictive, have broad application prospects;
(2) present invention obtains the CD59 gene order of Epinephelus coioides for the first time, not only enriches the gene pool of grouper,
And can be applied to preparation and reorganization albumen, antibacterial bacteriostatic additive and fish immunity preparation, exempt from for the physiology of Epinephelus coioides
Epidemic disease research provides new practical basis;
(3) Epinephelus coioides CD59 nucleotides sequence is listed in and is expressed by recombinant strain, it can be with mass production grouper CD59
Recombinant protein greatly reduces production cost, has very high economic value.
Detailed description of the invention
Fig. 1 is the electrophoretic identification (M of the pcr amplification product of Epinephelus coioides CD59 gene ORF:DNA molecular amount standard;
1:Grouper CD59 gene ORF full length sequence PCR product);
Fig. 2 is the electroresis appraisal of the pcr amplification product of grouper CD59 gene ORF ligase cut-grafting head (EcoRI, XhoI)
Scheme (M:DNA molecular amount standard;1:Grouper CD59 gene ORF full length sequence PCR product with digestion connector);
Fig. 3 is the electrophoretic identification (M of cloning vector pMD18-T-CD59 double digestion (EcoRI, XhoI):DNA molecular amount mark
It is quasi-;1:PMD18-T-CD59 plasmid;2:Double digestion pMD18-T-CD59 plasmid);
Fig. 4 is the electrophoretic identification (M of expression vector pGEX4T-2-CD59 double digestion (EcoRI, XhoI):DNA molecular amount
Standard;1:PGEX4T-2-CD59 plasmid;2:Double digestion pGEX4T-2-CD59 plasmid);
Fig. 5 be recombinant bacterial strain pGEX4T-2-CD59-BL21 expression product CD59 recombinant protein PAGE electrophoretic analysis figure and
Western blot qualification figure (M:Protein Marker;1:PGEX4T-2-BL21 induced product;2:GST recombinant protein after purification;
3:The western blot qualification figure of GST recombinant protein after purification;4:PGEX4T-2-CD59-BL21 induced product;5:CD59 after purification
Recombinant protein;6:The western blot qualification figure of CD59 recombinant protein after purification);
Fig. 6 is pGEX4T-2-CD59 expression vector establishment schematic diagram;
Fig. 7 is Epinephelus coioides CD59 amino acid sequence and people CD59 Amino acid sequences alignment figure;
Fig. 8 is Epinephelus coioides CD59 Protein Epitopes predictive analysis results;
Fig. 9 is ELISA Binding experiment (the different words of Epinephelus coioides CD59 recombinant protein and vibrio alginolyticus under various concentration
Matrix shows significant difference compared with the control group, P < 0.05);
Figure 10 is influence (the different letter expressions under the processing of Epinephelus coioides CD59 recombinant protein to vibrio alginolyticus growth
There are significant difference, P < 0.05 compared with the control group);
Figure 11 is the influence formed under the processing of Epinephelus coioides CD59 recombinant protein to vibrio alginolyticus mushroom.
Specific embodiment
Below in conjunction with specific experiment, the present invention is further explained, it should be appreciated that following experiment be merely to illustrate the present invention and
It is not used in and limits the scope of the invention.
Molecular biology experiment technology employed in following embodiment include PCR amplification, plasmid extract, plasmid conversion,
DNA fragmentation connection, digestion, gel electrophoresis etc., unless otherwise specified, usually conventionally operate, for details, reference can be made to《Molecule
Cloning experimentation guide》(third edition) (Sambrook J, Russell DW, Janssen K, Argentine J. Huang Peitang etc. is translated,
2002, Beijing:Science Press), or according to the normal condition proposed by manufacturer.
One, the ORF of Epinephelus coioides CD59 gene is obtained by design degenerate primer
According to conservative of the CD59 amino acid sequence in each species, degenerate primer is designed.First primer be
CD59F1, sequence are:5 '-ATGAAGCACTCCCTGGGGAT (SEQ ID NO.3), Article 2 primer are CD59R1, and sequence is:
5 '-TCAGTGGATGCACCACCACA (SEQ ID NO.4), with M-MLV reverse transcriptase kit
The Epinephelus coioides liver cDNA that (Promega, Madison, WI, USA) reverse transcription obtains is template, by touchdown
Round pcr obtains pcr amplification product, is sequenced and is compared to it, be determined as CD59 gene, the length is 354bp (SEQ
ID NO.2), and deduce its amino acid sequence (SEQ ID NO.1).PCR reaction condition is:94 DEG C of initial denaturation 4min;(1)94
DEG C denaturation 30s, anneal 72 DEG C of 30s, totally 5 circulation;(2) 94 DEG C of denaturation 30s, anneal 70 DEG C of 30s, extends 72 DEG C, totally 5 are followed
Ring;(3) 94 DEG C of denaturation 30s, anneal 53 DEG C of 30s, extends 72 DEG C, totally 30 circulations;Last 72 DEG C are continued to extend 10min.PCR expands
The electrophoretogram of volume increase object is shown in Fig. 1.
Two, bioinformatics method analyzes Epinephelus coioides CD59 protein sequence
Using two sequence analysis softwares of clustal-X and GeneDoc, by the amino acid sequence of Epinephelus coioides CD59 gene
The amino acid sequence of column and people CD59 gene carries out sequence alignment, finds Epinephelus coioides CD59 protein sequence and mankind's CD59 egg
Bai Xulie has higher homology (Fig. 7), and the epitope (Fig. 8) of Epinephelus coioides CD59 albumen is analyzed by software.
Three, the synthesis of Epinephelus coioides CD59 gene order
According to the cDNA sequence for the Epinephelus coioides CD59 gene analyzed, the primer at design synthesis upstream and downstream both ends.On
Swimming primer is CD59F2, and sequence is:5'-CCGGAATTCCGATGAAGCACTCCCTGGGGAT(SEQ ID NO.5);Draw in downstream
Object is CD59R2, and sequence is:5'-CCGCTCGAGCTCAGTGGATGCACCACCACA(SEQ ID NO.6).It is obtained with reverse transcription
Epinephelus coioides liver cDNA be template, the CD59 gene through PCR method amplification grouper, PCR reaction condition is:94 DEG C pre-
It is denaturalized 3min;94 DEG C are denaturalized 30 seconds, and 55 DEG C are annealed 30 seconds, and 72 DEG C extend 30 minutes, and totally 40 recycle;Last 72 DEG C extend 10 points
Clock.The electrophoretic identification of pcr amplification product is shown in Fig. 2.
Four, the building of the cloning vector pMD18-T-CD59 of the sequence of CD59 containing Epinephelus coioides
Above-mentioned genetic fragment obtained is isolated and purified, then with pMD18-T (TAKARA) carrier according to the kit
4 DEG C of system of offer connect overnight (13h), and connection product is converted bacillus coli DH 5 alpha, through Amp+ resistance and blue hickie screening
Positive colony out;Plasmid is extracted by the small extraction reagent kit of plasmid (Omega, USA), plasmid is verified and is sequenced by double digestion and tests
Card, it was demonstrated that Epinephelus coioides CD59 sequence is cloned into carrier, is named as pMD18-T-CD59, and cloning vector converts Escherichia coli
The obtained recombinant bacterial strain of DH5 α is named as pMD18-T-CD59-DH5 α.Using EcoRI, XhoI to cloning vector pMD18-T-
CD59 carries out double digestion, and restriction enzyme mapping is shown in Fig. 3.
Five, the building of the expression vector pGEX4T-2-CD59 of the sequence of CD59 containing Epinephelus coioides
Cloning vector pMD18-T-CD59 through it is small mention plasmid kit (Omega, USA) extracting after, use restriction enzyme
EcoRI and XhoI carries out double digestion, carries out agarose gel electrophoresis, and product is usedGel Extraction Kit is returned
It receives, isolates and purifies the Epinephelus coioides CD59 sequence of about 354bp;
Vector plasmid pGEX4T-2 isolates and purifies the sheet of 3.6kb after restriction enzyme EcoRI and XhoI double digestion
Section, the genetic fragment with the Epinephelus coioides CD59 of about 354bp is with 1:3 ratios mixing, with T4 ligase in 16 DEG C of connections overnight
(about 15h).Then, CaCl is used2Plasmid is transferred in bacillus coli DH 5 alpha by method, provides the conversion of Amp+ resistance in LB plate screening
Son.Plasmid is extracted with standard method, the sequencing of Invitrogen company is sent to, sequencing result is compared, is angled tape lithosporic
The gene order of fish CD59, and be properly inserted into expression vector pGEX4T-2, recombinant plasmid is named as pGEX4T-2-CD59.
Plasmid construction process is shown in Fig. 7.PGEX4T-2-CD59 is carried to expression using EcoRI and XhoI and carries out double digestion, restriction analysis figure is shown in
Fig. 4.
Six, the E. coli recombinant stain pGEX4T-2-CD59-BL21 structure of energy high efficient expression Epinephelus coioides CD59 albumen
It builds
According to CaCl2Above-mentioned obtained purpose recombinant plasmid is transferred to e. coli bl21, had with LB plate screening by method
The transformant of Amp resistance, the recombinant bacterium are pGEX4T-2-CD59-BL21.
Seven, recombination Epinephelus coioides CD59 albumen is produced using Escherichia coli recombinant strain pGEX4T-2-CD59-BL21
Recombination BL21 monoclonal engineering bacteria is picked them separately, is inoculated in the LB culture medium containing AMP resistance, 37 DEG C,
200rpm culture expands strain and renews the fresh LB culture medium containing AMP resistance, works as OD600Stop when to 0.8, and is added about
1mM IPTG induces 4h.7000rpm after induction, 4 DEG C of collection thallus.TEB buffer is added to suspend to thallus, is added suitable
The lysozyme of amount, 4 DEG C are overnight, then again in ice bath ultrasonication to bright clear.Again with containing 30%Trition X-100's
Buffer A is resuspended, then stands 30min on ice, and it is molten to albumen progress at room temperature that the buffer B containing urea is added
Solution.According to the method for GST bind resin (Millipore), dissolved albumen is purified, as a result sees Fig. 5.
Eight, Epinephelus coioides CD59 proteantigen activity identification is tested
Immunological identification is carried out to recombination Epinephelus coioides CD59 albumen using western blot method.Wherein, primary antibody uses mouse
Source GST monoclonal antibody (Novagen), secondary antibody use horse anti-mouse IgG-AP (Ding Guo biotech firm).As a result such as Fig. 5, display
Source of mouse GST monoclonal antibody can identify the recombination Epinephelus coioides CD59 albumen by Bacillus coli expression, it was demonstrated that obtained egg
White is recombination Epinephelus coioides CD59 albumen.
Nine, vibrio alginolyticus ELISA is tested
Vibrio alginolyticus is inoculated in LB culture medium, 37 DEG C, continuously cultivates in 200rpm to OD600=0.8, it is used after being then centrifuged for
PBS suspends again to strain, and adjusting bacteria concentration is 1 × 107CFU ml-1, and above-mentioned vibrios is inoculated in 96 hole Elisa plates
In.4 DEG C overnight after, 5% skim milk carries out closing 2h to Elisa plate, then after being cleaned with 0.5%Tween-20/PBS,
5 μ g/ml are separately added into, the GST albumen or CD59 albumen of 50 μ g/ml, 100 μ g/ml and 200 μ g/ml are incubated for 2h at room temperature.So
After being cleaned afterwards with 0.5%Tween-20/PBS, respectively with source of mouse GST-tag primary antibody and horse anti-mouse HRP secondary antibody to Elisa plate into
Row closing.200 μ l TMB solution are finally added in a dark environment, 2M sulfuric acid is then added, display reaction is terminated, and
In OD450Lower carry out reading Analysis.Calculation formula:Experimental group OD450Reading/negative control group OD450Reading, is as a result shown in Fig. 9.
As the result is shown:With GST control group it was found that, when be added CD59 protein concentration be gradually increasing when, with molten algae
The combination ratio of vibrios gradually raises, and illustrates that Epinephelus coioides CD59 recombinant protein and vibrio alginolyticus have binding ability, and
And there are dose relationships.
Ten, vibrio alginolyticus Cell suppression test
Vibrio alginolyticus is inoculated in LB culture medium, 37 DEG C, continuously cultivates in 200rpm to OD600=0.8, it is used after being then centrifuged for
PBS solution suspends again to strain, and adjusting bacteria concentration is 2 × 105CFU ml-1.With 49:Concentration is respectively 5 μ by 1 ratio
The GST albumen or CD59 albumen of g/ml and 100 μ g/ml and vibrio alginolyticus carry out incubation at room temperature 2h, are then centrifuged for supernatant, use
Tween-20/PBS cleans bacterium precipitating, and then above-mentioned bacterium mixture is inoculated in respectively in the LB culture medium of 10ml,
37 DEG C are incubated overnight, 4h the and 12h sample detection bacterium OD after culture600, the result is shown in Figure 10.
As the result is shown:With PBS group and GST control group it was found that, by 100 μ g/ml CD59 albumen processing after molten algae
Vibrios OD600Substantially less than control group and PBS group illustrate that the CD59 protein concentration of 100 μ g/ml can effectively inhibit inoculation
Concentration is 2 × 105CFU ml-1Vibrio alginolyticus growth.
11, vibrio alginolyticus mushroom forms Inhibition test
Algae vibrios is inoculated in LB culture medium, 37 DEG C, continuously cultivates in 200rpm to OD600=0.8, PBS is used after being then centrifuged for
Solution suspends again to strain, and adjusting bacteria concentration is 2 × 105CFU ml-1.With 49:Concentration is respectively 5 μ g/ml by 1 ratio
Incubation at room temperature 2h is carried out with the GST albumen or CD59 albumen of 100 μ g/ml and vibrio alginolyticus, supernatant is then centrifuged for, uses Tween-
20/PBS cleans bacterium precipitating, is then respectively coated on LB plate, is incubated overnight, the result is shown in Figure 11.
The result shows that:With PBS group and GST control group it was found that, by 100 μ g/ml CD59 albumen processing after molten algae
The bacterium colony of vibrios forms number and is substantially less than control group and PBS group, illustrates that the CD59 protein concentration of 100 μ g/ml can be effective
It is 2 × 10 that ground, which inhibits inoculum density,5CFU ml-1Vibrio alginolyticus growth.
The above experiment shows:Epinephelus coioides CD59 albumen has the binding ability with vibrio alginolyticus, and presents agent
Magnitude relation, while with the raising of protein concentration, the growth of vibrio alginolyticus can be effectively inhibited.It can be seen that recombinant protein
CD59 can have potentiality to be exploited in terms of antibacterial bacteriostatic, it can also be used to prepare aquatic livestock immune formulation or feed addictive.
SEQUENCE LISTING
<110>South China Normal University
<120>A kind of Epinephelus coioides antimicrobial petide and its application
<130> 2018.6.29
<160> 6
<170> PatentIn version 3.5
<210> 1
<211> 117
<212> PRT
<213> Epinepheluscoioides
<400> 1
Met Lys Arg Ser Leu Gly Ile Cys Leu Val Ile Cys Ser Ala Leu Ile
1 5 10 15
Gly Leu Gly Ser Ala Ile Arg Cys Tyr Ser Cys Lys Asp Tyr Thr Ala
20 25 30
Ser Cys Thr Lys Gln Arg Glu Cys Ser Tyr Asp Asp Ala Cys Leu Thr
35 40 45
Leu Thr Glu Arg Gly Gly Met Thr Tyr Arg Gln Cys Leu Lys Tyr Ser
50 55 60
Asp Cys Glu Tyr Gly Arg Leu Ser Gln Met Phe Pro Gln Val Ser Ser
65 70 75 80
Phe Thr Phe Lys Cys Cys Asn Ser Asp Leu Cys Asn Ser Ala Pro Ser
85 90 95
Ser Ala Ser Met Ser Val Ile Gly Leu Leu Ala Ser Ala Ala Val Met
100 105 110
Trp Trp Cys Ile His
115
<210> 2
<211> 354
<212> DNA
<213> Epinepheluscoioides
<400> 2
atgaagcgct ccctggggat ctgtctggtg atctgctccg ctctgatcgg actgggatcg 60
gccatccggt gttacagctg taaggactac acagccagct gcaccaaaca acgagagtgt 120
agctatgacg atgcctgtct cacactcacc gagagaggtg gaatgactta ccgtcagtgt 180
ctgaagtact cagactgtga gtacggccga ctgtcccaaa tgttccccca ggtctccagt 240
ttcaccttca agtgctgcaa ctcagatctg tgtaactccg ccccctcctc tgcatcgatg 300
tctgtgattg gtcttctggc ctcagcggca gtcatgtggt ggtgcatcca ctga 354
<210> 3
<211> 20
<212> DNA
<213>It is artificial synthesized
<400> 3
atgaagcact ccctggggat 20
<210> 4
<211> 20
<212> DNA
<213>It is artificial synthesized
<400> 4
tcagtggatg caccaccaca 20
<210> 5
<211> 31
<212> DNA
<213>It is artificial synthesized
<400> 5
ccggaattcc gatgaagcac tccctgggga t 31
<210> 6
<211> 30
<212> DNA
<213>It is artificial synthesized
<400> 6
ccgctcgagc tcagtggatg caccaccaca 30
Claims (9)
1. a kind of Epinephelus coioides antimicrobial petide, antibacterial peptide is Epinephelus coioides CD59 albumen, amino acid sequence such as SEQ ID
Shown in NO.1 or amino acid sequence shown in SEQ ID NO.1 is substituted, lacks and/or increases one or more amino
It is sour and/or end modified and there is same or higher active albumen.
2. encoding the gene of Epinephelus coioides antimicrobial petide described in claim 1.
3. gene according to claim 2, nucleotide sequence is as shown in SEQ ID NO.2.
4. a kind of cloning vector contains gene described in claim 2 or 3.
5. a kind of expression vector contains gene described in claim 2 or 3.
6. the method for producing Epinephelus coioides antimicrobial petide, including expression vector described in claim 5 is imported in host cell,
Expression obtains Epinephelus coioides antimicrobial petide.
7. application of the Epinephelus coioides antimicrobial petide described in claim 1 in preparation vibrio alginolyticus growth inhibitor.
8. a kind of aquatic livestock immune formulation, wherein containing Epinephelus coioides antimicrobial petide described in claim 1.
9. a kind of aquatic animal feed additive, wherein containing Epinephelus coioides antimicrobial petide described in claim 1.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810711517.XA CN108892718B (en) | 2018-07-03 | 2018-07-03 | Epinephelus coioides antibacterial peptide and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810711517.XA CN108892718B (en) | 2018-07-03 | 2018-07-03 | Epinephelus coioides antibacterial peptide and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108892718A true CN108892718A (en) | 2018-11-27 |
CN108892718B CN108892718B (en) | 2021-06-15 |
Family
ID=64347619
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810711517.XA Active CN108892718B (en) | 2018-07-03 | 2018-07-03 | Epinephelus coioides antibacterial peptide and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108892718B (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113861271A (en) * | 2021-10-28 | 2021-12-31 | 集美大学 | Dried salted yellow croaker flavor peptide Tit5 and application thereof |
CN113912676A (en) * | 2021-10-28 | 2022-01-11 | 集美大学 | Vinasse yellow croaker antibacterial peptide FAH34 and application thereof |
-
2018
- 2018-07-03 CN CN201810711517.XA patent/CN108892718B/en active Active
Non-Patent Citations (2)
Title |
---|
GAN Z. ET AL.: "CD59 glycoprotein-like precursor [Oreochromis niloticus]. GENBANK VERSION NO.: NP_001298266.1", 《GENBANK》 * |
ZHEN GAN ET AL.: "Molecular and functional characterization of CD59 from Nile tilapia (Oreochromis niloticus) involved in the immune response to Streptococcus agalactiae", 《FISH & SHELLFISH IMMUNOLOGY》 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113861271A (en) * | 2021-10-28 | 2021-12-31 | 集美大学 | Dried salted yellow croaker flavor peptide Tit5 and application thereof |
CN113912676A (en) * | 2021-10-28 | 2022-01-11 | 集美大学 | Vinasse yellow croaker antibacterial peptide FAH34 and application thereof |
CN113912676B (en) * | 2021-10-28 | 2023-02-17 | 集美大学 | Vinasse yellow croaker antibacterial peptide FAH34 and application thereof |
CN113861271B (en) * | 2021-10-28 | 2023-02-17 | 集美大学 | Dried salted yellow croaker flavor peptide Tit5 and application thereof |
Also Published As
Publication number | Publication date |
---|---|
CN108892718B (en) | 2021-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Ko et al. | Molecular characterization, transcriptional profiling, and antibacterial potential of G-type lysozyme from seahorse (Hippocampus abdominalis) | |
Bathige et al. | Evidences for the involvement of an invertebrate goose-type lysozyme in disk abalone immunity: Cloning, expression analysis and antimicrobial activity | |
CN102304484B (en) | New strain of pseudoalteromonas flavipulchra and use thereof | |
CN110551732A (en) | Trachinotus ovatus antimicrobial peptide LEAP-2 gene and application thereof | |
CN108892718A (en) | A kind of Epinephelus coioides antimicrobial petide and its application | |
Tian et al. | Expression of c-type lysozyme gene in sea cucumber (Apostichopus japonicus) is highly regulated and time dependent after salt stress | |
CN107937406B (en) | Novel Crustin gene of portunus trituberculatus and application of recombinant protein thereof | |
Zhang et al. | Identification of two ferritin genes and their expression profiles in response to bacterial challenge in noble scallop Chlamys nobilis with different carotenoids content | |
Chen et al. | Functional characterization of an ER-stress responding Crustin gene in Litopenaeus vannamei | |
Shanthi et al. | cDNA cloning, characterization and expression analysis of a novel antimicrobial peptide gene penaeidin-3 (Fi-Pen3) from the haemocytes of Indian white shrimp Fenneropenaeus indicus | |
Song et al. | Peroxiredoxin 1 from cuttlefish (Sepiella maindroni): Molecular characterization of development and its immune response against Vibrio alginolyticus | |
CN101525617B (en) | Eriocheir sinensis Crustin-1 gene and in-vitro recombination expression | |
CN102816221A (en) | Chicken E. tenella MA1 (EtMA1) gene, vector, recombinant strain, EtMA1 protein, EtMA1-Outside domain, and use of the EtMA1 protein and the EtMA1-Outside domain | |
CN104961811A (en) | Aeromonas hydrophila outer membrane protein gene prokaryotic expression protein and application thereof | |
CN107602686B (en) | Polypeptide with resistance to gram-positive bacteria | |
CN101824435A (en) | Expression system of tilapia neuropeptide Y recombinant protein | |
CN115873733B (en) | Pichia pastoris strain for high yield of lysozyme and application thereof | |
CN114891760B (en) | Cynoglossus semilaevis CHST12 protein and application thereof in antibiosis | |
JP2014533931A5 (en) | ||
CN107653255B (en) | Penaeus monodon peroxidase reductase gene Prx5 and application thereof | |
CN107365372A (en) | A kind of Environment of Litopenaeus vannamei Low L-type agglutinin and its encoding gene and application | |
RU2014117659A (en) | AMINO ACID SEQUENCES FOR PATHOGEN CONTROL | |
CN109868277A (en) | Sepiella maindroni Toll-like receptor gene and its immune defense function | |
CN103724415A (en) | Epinephelus coioides sex control gene Rspo1 and preparation method and application thereof | |
CN102199202B (en) | Gene of recombinant fungal immunomodulatory protein between ganodermas, protein coded thereby, and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |